 | ||
|
| Home Annual/Quarterly Updates About Us
|
Polymedix, Inc. Summary: According to the law firm press release, PolyMedix is a clinical stage biotechnology Company that develops drugs for the treatment of serious acute care conditions. Throughout the Class Period, the Company had two experimental compounds in clinical trials, PMX-30063 and PMX-60056. One of these prospective drugs, PMX-60056, was a cardiovascular compound that was intended to reverse the activity of common blood clotting agents in order to avoid the risk of stroke.
The complaint alleges that beginning on March 7, 2011, the Company, along with its Chief Executive Officer, Chief Financial Officer, and Vice President of Cardiovascular Clinical Development, issued a series of materially false and misleading statements to investors about PMX-60056’s commercial viability, safety, and market potential that caused shares of PolyMedix to trade at artificially high prices. Specifically, it is alleged that officials at PolyMedix failed disclose to investors that: (a) the Company’s experimental compounds caused hypotension more often and at lower doses than acknowledged; (b) varying doses of the compound would not eliminate its adverse side effects on a patient’s blood pressure; and (c) as a result, the development of the Company’s drug pipeline and the business prospects of PolyMedix were at significant risk.
On May 10, 2012, PolyMedix issued a press release disclosing to investors for the time that the Company was halting patient enrollment in clinical trials for PMX-60056 “due to observations of reductions in blood pressure.” When the true state of PMX-60056’s clinical development and adverse side effects became public, shares of PolyMedix’s common stock declined a staggering 29%, closing on May 11, 2012 at just $0.36 per share.
On September 19, 2012, the Court issued an Order appointing lead plaintiff and approving the selection of lead counsel. On January 28, 2013, lead plaintiffs filed their amended complaint.
INDUSTRY CLASSIFICATION:
SIC Code: 2834
Sector:
Industry:
| COMPANY/ISSUER NAME: | Polymedix, Inc. |
| COMPANY/ISSUER TICKER: | PYMX |
| COMPANY WEBSITE: |
| FIRST IDENTIFIED COMPLAINT IN THE DATABASE | |||||||||||||||||
| Graham Anderson, et al. v. Polymedix, Inc., et al. | |||||||||||||||||
| |||||||||||||||||
| DOCUMENTS FOR THE FIRST IDENTIFIED COMPLAINT | |||
| Class Action Complaint for Violation of Federal Securities Laws | |||
| Type: Complaint | Date on the document: 07/02/2012 | ||
| U.S. District Court Civil Docket | |||
| Type: Docket | Date on the document: 07/02/2012 | ||
| Order Granting Movant Polymedix Group's Motion For Appointment As Lead Plaintiff And Approval Of Selection Of Counsel | |||
| Type: Order Appointing LP/LC | Date on the document: 09/19/2012 | ||
| REFERENCE COMPLAINT | |||||||||||||||||
| Graham Anderson, et al. v. Polymedix, Inc., et al. | |||||||||||||||||
| |||||||||||||||||
| DOCUMENTS FOR THE REFERENCE COMPLAINT | |||
| Amended Class Action Complaint for Violation of Federal Securities Laws | |||
| Type: Complaint | Date on the document: 01/28/2013 | ||
| OTHER DOCUMENTS | |||
| Case Name and/or Number: | |||
| Type: | Date on the document: | ||
WARNING AND DISCLAIMER OF LIABILITY:
The information included on this Web site, whether provided by personnel employed by Stanford Law School or by third parties, is provided for research and teaching purposes only. Neither Stanford University, Stanford Law School, nor any of their employees, agents, contractors, or affiliates warrant the accuracy or completeness of the information or analyses displayed herein, and we caution all readers that inclusion of any information on this site does not constitute an endorsement of the truthfulness or accuracy of that information. In particular, this Web site contains complaints and other documents filed in federal and state courts, which make allegations that may or may not be accurate. No reader should, on the basis of information contained in or referenced by this Web site, assume that any of these allegations are truthful.
Go to Search page | Go to Case Index page | Back to Top